Skip to main content

Table 2 Characteristics of the 14,967 selected esophageal cancer patients, 2002–2011

From: Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002–2011)

Variable

Number of patients [cases (%)]

Region

 Eastern

7053 (47.12)

 Central

4287 (28.64)

 Western

3627 (24.23)

Hospital type

 General

3430 (22.92)

 Specialized

11,537 (77.08)

Hospital level

 3A

13,752 (91.88)

 3A less

1215 (8.12)

Gender

 Male

11,717 (78.29)

 Female

3250 (21.71)

Age at diagnosis (years)

 <45

666 (4.45)

 45–54

3252 (21.73)

 55–64

5683 (37.97)

 ≥65

5366 (35.85)

Pathologic typea

 Squamous cell carcinoma

12,401 (85.06)

 Others

2178 (14.94)

Clinical stage

 I

1131 (7.56)

 II

5186 (34.65)

 III

4695 (31.37)

 IV

2880 (19.24)

 Not reported

1075 (7.18)

Morphologic verification

13,332 (89.10)

Number of clinical visits per case

 1

9564 (63.90)

 2

2725 (18.21)

 3

1176 (7.86)

 4+

1502 (10.04)

Type of therapyb

 Surgery

5168 (34.75)

 Surgery and chemotherapy

3000 (20.17)

 Radiotherapy

1982 (13.33)

 Chemotherapy

1690 (11.36)

 Radiotherapy and chemotherapy

1310 (8.81)

 Surgery and radiotherapy

386 (2.60)

 Palliative care

928 (6.24)

 Others

408 (2.74)

Comorbidities

3877 (25.9)

Complications

1235 (8.25)

  1. aThe data for 388 patients were missing
  2. bThe data for 95 patients were missing